![](https://cdmf.org.br/wp-content/uploads/2019/07/In-vitro-Evidence-of-Human-Immune-Responsiveness-Shows-the-Improved-Potential-of-a-Recombinant-BCG-Strain-for-Bladder-Cancer-Treatment.png)
Artigo
In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment
In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment Abstract: The live attenuated mycobacterial strain BCG, in use as vaccine against tuberculosis, is considered the […]